Millipore Sigma Vibrant Logo

444152 MDM2 Antagonist IV, Nutlin-3a - CAS 675576-98-4 - Calbiochem

View Products on Sigmaaldrich.com
444152
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      CAS #Empirical Formula
      675576-98-4C₃₀H₃₀Cl₂N₄O₄
      Description
      OverviewA cell-permeable and highly potent active enantiomer of Nutlin-3 (Cat. No. 444143) that binds to the p53-binding pocket and blocks the interaction of p53 and MDM2 (IC50 = 90 nM). Exhibits over 150-fold greater affinity for MDM2 than its less active enantiomer, Nutlin-3b. Induces p53 mediated apoptosis by both transcription-dependent and independent mechanisms. Shown to greatly potentiate the cytotoxic effects of chemotherapeutic agents and reduce tumor burden in vivo. Also shown to overcome ATM-mediated resistance to fludarabine in chronic lymphocyte leukemia. Cells treated with Nutlin-3a permanently lose their ability to proliferate and enter into a pattern of permanent senescence. Mouse embryonic fibroblasts with p53+/+MEFs show significantly reduced reprogramming capabilities following Nutlin-3a treatment.
      Catalogue Number444152
      Brand Family Calbiochem®
      Synonyms(-)-4-(4,5-bis-(4-Chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydroimidazole-1-carbonyl)piperazine-2-one
      References
      ReferencesOhnstad, H.O., et al. 2011. BMC Cancer 11, 211.
      Shen, H. and Maki, C.G., 2010. J. Biol. Chem. 285, 23105.
      Kawamura, T., et al. 2009. Nature 460, 1140.
      Kojima, K., et al. 2006. Blood 108, 993.
      Laurie, N.A., et al. 2006. Nature 444, 61.
      Tovar, C., et al. 2006. Proc. Natl. Acad. Sci. USA 103, 1888.
      Vassilev, L.T. 2006. Trends Mol Med. 13, 23.
      Thompson, T., et al. 2004. J. Biol. Chem. 279, 53015.
      Vassilev, L.T., et al. 2004. Science 303, 844.
      Product Information
      CAS number675576-98-4
      FormWhite powder
      Hill FormulaC₃₀H₃₀Cl₂N₄O₄
      Chemical formulaC₃₀H₃₀Cl₂N₄O₄
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      444152 0

      Documentation

      MDM2 Antagonist IV, Nutlin-3a - CAS 675576-98-4 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      MDM2 Antagonist IV, Nutlin-3a - CAS 675576-98-4 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      444152

      Références bibliographiques

      Aperçu de la référence bibliographique
      Ohnstad, H.O., et al. 2011. BMC Cancer 11, 211.
      Shen, H. and Maki, C.G., 2010. J. Biol. Chem. 285, 23105.
      Kawamura, T., et al. 2009. Nature 460, 1140.
      Kojima, K., et al. 2006. Blood 108, 993.
      Laurie, N.A., et al. 2006. Nature 444, 61.
      Tovar, C., et al. 2006. Proc. Natl. Acad. Sci. USA 103, 1888.
      Vassilev, L.T. 2006. Trends Mol Med. 13, 23.
      Thompson, T., et al. 2004. J. Biol. Chem. 279, 53015.
      Vassilev, L.T., et al. 2004. Science 303, 844.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision10-August-2012 JSW
      Synonyms(-)-4-(4,5-bis-(4-Chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydroimidazole-1-carbonyl)piperazine-2-one
      DescriptionA cell-permeable and highly potent active enantiomer of Nutlin-3 (Cat. No. 444143) that binds to the p53-binding pocket and blocks the interaction of p53 and MDM2 (IC50 = 90 nM). Exhibits over 150-fold greater affinity for MDM2 than its less active enantiomer, Nutlin-3b. Induces p53 mediated apoptosis by both transcription-dependent and independent mechanisms. Shown to greatly potentiate the cytotoxic effects of chemotherapeutic agents and reduce tumor burden in vivo. Also shown to overcome ATM-mediated resistance to fludarabine in chronic lymphocyte leukemia. Cells treated with Nutlin-3a permanently lose their ability to proliferate and enter into a pattern of permanent senescence. Mouse embryonic fibroblasts with p53+/+MEFs show significantly reduced reprogramming capabilities following Nutlin-3a treatment.
      FormWhite powder
      Intert gas (Yes/No) Packaged under inert gas
      CAS number675576-98-4
      Chemical formulaC₃₀H₃₀Cl₂N₄O₄
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesOhnstad, H.O., et al. 2011. BMC Cancer 11, 211.
      Shen, H. and Maki, C.G., 2010. J. Biol. Chem. 285, 23105.
      Kawamura, T., et al. 2009. Nature 460, 1140.
      Kojima, K., et al. 2006. Blood 108, 993.
      Laurie, N.A., et al. 2006. Nature 444, 61.
      Tovar, C., et al. 2006. Proc. Natl. Acad. Sci. USA 103, 1888.
      Vassilev, L.T. 2006. Trends Mol Med. 13, 23.
      Thompson, T., et al. 2004. J. Biol. Chem. 279, 53015.
      Vassilev, L.T., et al. 2004. Science 303, 844.